110 related articles for article (PubMed ID: 12506183)
1. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
Blaney SM; Heideman R; Berg S; Adamson P; Gillespie A; Geyer JR; Packer R; Matthay K; Jaeckle K; Cole D; Kuttesch N; Poplack DG; Balis FM
J Clin Oncol; 2003 Jan; 21(1):143-7. PubMed ID: 12506183
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.
Bomgaars L; Geyer JR; Franklin J; Dahl G; Park J; Winick NJ; Klenke R; Berg SL; Blaney SM
J Clin Oncol; 2004 Oct; 22(19):3916-21. PubMed ID: 15459213
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Blaney SM; Balis FM; Berg S; Arndt CA; Heideman R; Geyer JR; Packer R; Adamson PC; Jaeckle K; Klenke R; Aikin A; Murphy R; McCully C; Poplack DG
J Clin Oncol; 2005 Mar; 23(7):1555-63. PubMed ID: 15735131
[TBL] [Abstract][Full Text] [Related]
6. A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
Blaney SM; Tagen M; Onar-Thomas A; Berg SL; Gururangan S; Scorsone K; Su J; Goldman S; Kieran MW; Kun L; Boyett J; Stewart C
Pediatr Blood Cancer; 2013 Apr; 60(4):627-32. PubMed ID: 23002039
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal topotecan in adult patients with neoplastic meningitis.
Gammon DC; Bhatt MS; Tran L; Van Horn A; Benvenuti M; Glantz MJ
Am J Health Syst Pharm; 2006 Nov; 63(21):2083-6. PubMed ID: 17057045
[TBL] [Abstract][Full Text] [Related]
8. Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion.
Blaney SM; Balis FM; Cole DE; Craig C; Reid JM; Ames MM; Krailo M; Reaman G; Hammond D; Poplack DG
Cancer Res; 1993 Mar; 53(5):1032-6. PubMed ID: 8439950
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor.
Abbruzzese JL; Madden T; Sugarman SM; Ellis AL; Loughlin S; Hess KR; Newman RA; Zwelling LA; Raber MN
Clin Cancer Res; 1996 Sep; 2(9):1489-97. PubMed ID: 9816325
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Blaney SM; Boyett J; Friedman H; Gajjar A; Geyer R; Horowtiz M; Hunt D; Kieran M; Kun L; Packer R; Phillips P; Pollack IF; Prados M; Heideman R
J Clin Oncol; 2005 Jan; 23(3):525-31. PubMed ID: 15659498
[TBL] [Abstract][Full Text] [Related]
11. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
Wagner S; Erdlenbruch B; Längler A; Gnekow A; Kühl J; Albani M; Völpel S; Bucsky P; Emser A; Peters O; Wolff JE
Cancer; 2004 Apr; 100(8):1750-7. PubMed ID: 15073866
[TBL] [Abstract][Full Text] [Related]
12. A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
Groves MD; Glantz MJ; Chamberlain MC; Baumgartner KE; Conrad CA; Hsu S; Wefel JS; Gilbert MR; Ictech S; Hunter KU; Forman AD; Puduvalli VK; Colman H; Hess KR; Yung WK
Neuro Oncol; 2008 Apr; 10(2):208-15. PubMed ID: 18316473
[TBL] [Abstract][Full Text] [Related]
13. Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
Potter SL; Berg S; Ingle AM; Krailo M; Adamson PC; Blaney SM
Pediatr Blood Cancer; 2012 Mar; 58(3):362-5. PubMed ID: 21910214
[TBL] [Abstract][Full Text] [Related]
14. A phase I and pharmacokinetic study of intraperitoneal topotecan.
Hofstra LS; Bos AM; de Vries EG; van der Zee AG; Beijnen JH; Rosing H; Mulder NH; Aalders JG; Willemse PH
Br J Cancer; 2001 Nov; 85(11):1627-33. PubMed ID: 11742479
[TBL] [Abstract][Full Text] [Related]
15. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
[TBL] [Abstract][Full Text] [Related]
16. Phase I and pharmacologic study of weekly bolus topotecan for advanced non-small-cell lung cancer.
Masuda N; Matsui K; Negoro S; Takeda K; Kudoh S; Nakagawa K; Mukaiyama A; Arase H; Yoshida P; Ijima T; Takada M; Fukuoka M
Clin Lung Cancer; 2010 Jul; 11(4):271-9. PubMed ID: 20630830
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
Berg SL; Balis FM; Zimm S; Murphy RF; Holcenberg J; Sato J; Reaman G; Steinherz P; Gillespie A; Doherty K
J Clin Oncol; 1992 Jan; 10(1):143-8. PubMed ID: 1727916
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of periocular topotecan in children with intraocular retinoblastoma.
Chantada GL; Fandino AC; Carcaboso AM; Lagomarsino E; de Davila MT; Guitter MR; Rose AB; Manzitti J; Bramuglia GF; Abramson DH
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1492-6. PubMed ID: 18978345
[TBL] [Abstract][Full Text] [Related]
19. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL
J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729
[TBL] [Abstract][Full Text] [Related]
20. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin.
Garcia AA; Roman L; Muderspach L; O'meara A; Facio G; Edwards S; Burnett A
Cancer Invest; 2005; 23(8):665-70. PubMed ID: 16377584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
